Skip to main content

Stryker Corporation income statement

  • SYK · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$309.64−0.88%Close 13 Nov 2026

Stryker Corporation reported revenue of $25.1 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), up 11.2% from fiscal 2024. Net income was $3.25 billion and diluted earnings per share $8.40.

From Stryker Corporation's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

Stryker Corporation income statement, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Revenue$6.00B$6.72B$6.72B$7.32B$8.31B$8.66B$9.02B$9.68B$9.95B$11.32B$12.44B$13.60B$14.88B$14.35B$17.11B$18.45B$20.50B$22.59B$25.12B$26.30B
Revenue growth—+12.0%+0.1%+8.9%+13.5%+4.2%+4.2%+7.2%+2.8%+13.9%+9.9%+9.3%+9.4%−3.6%+19.2%+7.8%+11.1%+10.2%+11.2%—
Cost of revenue$1.87B$2.13B$2.18B$2.29B$2.81B$2.78B$3.00B$3.32B$3.34B$3.83B$4.26B$4.66B$5.19B$5.29B$6.14B$6.87B$7.44B$8.15B$9.05B$9.12B
Gross profit$4.14B$4.59B$4.54B$5.03B$5.50B$5.88B$6.02B$6.36B$6.60B$7.50B$8.18B$8.94B$9.70B$9.06B$10.97B$11.58B$13.06B$14.44B$16.07B$17.18B
Gross margin68.9%68.3%67.5%68.8%66.2%67.9%66.7%65.7%66.4%66.3%65.7%65.7%65.1%63.1%64.1%62.8%63.7%63.9%64.0%65.3%
Research and development$375.3M$367.8M$336.0M$394.0M$462.0M$471.0M$536.0M$614.0M$625.0M$715.0M$787.0M$862.0M$971.0M$984.0M$1.24B$1.45B$1.39B$1.47B$1.62B$1.68B
Selling, general and administrative$2.39B$2.63B$2.51B$2.71B$3.15B$3.37B$3.47B$3.55B$3.61B$4.14B$4.55B$5.10B$5.36B$5.36B$6.43B$6.39B$7.11B$7.68B$8.65B$9.05B
Operating expenses$2.83B$3.07B$2.94B$3.28B$3.81B$4.13B$4.76B$5.11B$4.74B$5.33B$5.88B$6.40B$6.98B$6.83B$8.38B$8.74B$9.17B$10.75B$11.18B$11.75B
Operating income$1.31B$1.52B$1.59B$1.75B$1.69B$1.74B$1.26B$1.25B$1.86B$2.17B$2.30B$2.54B$2.71B$2.22B$2.58B$2.84B$3.89B$3.69B$4.89B$5.43B
Operating margin21.8%22.6%23.7%23.9%20.3%20.1%13.9%12.9%18.7%19.2%18.5%18.7%18.2%15.5%15.1%15.4%19.0%16.3%19.5%20.7%
Interest expense—$12.70M$14.00M$53.00M$56.00M$63.00M$83.00M$113.0M$108.0M$228.0M$247.0M$264.0M$287.0M$315.0M$337.0M$337.0M$356.0M$396.0M$582.0M$544.0M
Other income and expense$62.80M$61.20M$30.00M−$22.00M—−$36.00M−$44.00M−$86.00M−$126.0M−$254.0M−$234.0M−$181.0M−$151.0M−$269.0M−$303.0M−$158.0M$148.0M$212.0M$232.0M$269.0M
Income before tax$1.37B$1.58B$1.62B$1.73B$1.69B$1.71B$1.21B$1.16B$1.74B$1.92B$2.06B$2.36B$2.56B$1.95B$2.28B$2.68B$3.67B$3.49B$4.51B$5.12B
Income tax expense$383.4M$432.4M$517.0M$456.0M$341.0M$407.0M$206.0M$645.0M$296.0M$274.0M$1.04B−$1.20B$479.0M$355.0M$287.0M$325.0M$508.0M$499.0M$1.27B$1.49B
Effective tax rate28.0%27.4%31.8%26.4%20.2%23.9%17.0%55.6%17.1%14.3%50.6%−50.8%18.7%18.2%12.6%12.1%13.8%14.3%28.1%29.2%
Net income$1.02B$1.15B$1.11B$1.27B$1.34B$1.30B$1.01B$515.0M$1.44B$1.65B$1.02B$3.55B$2.08B$1.60B$1.99B$2.36B$3.17B$2.99B$3.25B$3.62B
Net margin17.0%17.1%16.5%17.4%16.2%15.0%11.2%5.3%14.5%14.5%8.2%26.1%14.0%11.1%11.7%12.8%15.4%13.2%12.9%13.8%
EPS · diluted$2.44$2.78$2.77$3.19$3.45$3.39$2.63$1.34$3.78$4.35$2.68$9.34$5.48$4.20$5.21$6.17$8.25$7.76$8.40$9.39
Diluted weighted average shares417M414M399M400M390M383M382M383M381M379M380M380M380M380M382M382M384M386M387M386M
Basic weighted average shares—408M397M396M387M381M379M379M377M374M374M374M374M376M377M378M380M381M382M383M
EBITDA$1.49B$1.71B$1.98B$2.16B$2.17B$2.23B$1.77B$1.83B$2.45B$2.93B$3.16B$3.50B$3.76B$3.30B$3.86B$4.12B$5.23B$5.12B$6.46B$7.05B
EBITDA margin24.8%25.5%29.4%29.5%26.1%25.7%19.6%18.9%24.6%25.8%25.4%25.8%25.2%23.0%22.5%22.3%25.5%22.6%25.7%26.8%
Depreciation & amortization$178.5M$195.4M$385.0M$410.0M$481.0M$486.0M$511.0M$586.0M$590.0M$752.0M$859.0M$966.0M$1.04B$1.08B$1.27B$1.28B$1.34B$1.43B$1.57B$1.61B
Stock-based compensation$61.30M$65.50M$62.00M$69.00M$75.00M$75.00M$76.00M$77.00M$86.00M$97.00M$113.0M$119.0M$127.0M$142.0M$171.0M$168.0M$205.0M$229.0M$243.0M$256.0M
Dividends per share$0.33$0.40$0.25$0.63$0.75$0.90$1.10$1.26$1.42$1.56——————————

Quarterly

Stryker Corporation income statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$5.82B$5.24B$5.42B$5.49B$6.44B$5.87B$6.02B$6.06B$7.17B$6.02B$6.59B$6.52B
Cost of revenue$2.11B$1.91B$2.01B$1.98B$2.26B$2.12B$2.18B$2.21B$2.54B$2.21B$2.09B$2.27B
Gross profit$3.70B$3.33B$3.42B$3.52B$4.17B$3.74B$3.84B$3.85B$4.63B$3.81B$4.50B$4.25B
Gross margin63.7%63.6%63.0%64.0%64.9%63.8%63.8%63.6%64.5%63.3%68.3%65.2%
Research and development$350.0M$368.0M$363.0M$377.0M$358.0M$405.0M$407.0M$410.0M$401.0M$413.0M$434.0M$433.0M
Selling, general and administrative$1.93B$1.84B$1.83B$1.89B$2.12B$2.30B$2.08B$2.04B$2.23B$2.28B$2.23B$2.31B
Operating expenses$2.45B$2.36B$2.37B$2.43B$3.59B$2.91B$2.73B$2.72B$2.82B$2.87B$2.84B$3.21B
Operating income$1.26B$972.0M$1.05B$1.08B$581.0M$837.0M$1.11B$1.14B$1.80B$936.0M$1.66B$1.03B
Operating margin21.6%18.5%19.4%19.7%9.0%14.3%18.5%18.7%25.2%15.5%25.2%15.9%
Interest expense——$96.00M$98.00M$104.0M$132.0M$159.0M$157.0M$129.0M$142.0M$136.0M$137.0M
Other income and expense$332.0M−$49.00M−$53.00M−$42.00M$356.0M$64.00M$62.00M$51.00M$55.00M$62.00M$46.00M$106.0M
Income before tax$1.23B$923.0M$998.0M$1.04B$528.0M$764.0M$1.02B$1.03B$1.71B$850.0M$1.56B$997.0M
Income tax expense$83.00M$135.0M$173.0M$209.0M−$18.00M$110.0M$132.0M$170.0M$856.0M$105.0M$288.0M$244.0M
Effective tax rate6.8%14.6%17.3%20.0%−3.4%14.4%13.0%16.5%50.2%12.4%18.4%24.5%
Net income$1.14B$788.0M$825.0M$834.0M$546.0M$654.0M$884.0M$859.0M$849.0M$745.0M$1.28B$753.0M
Net margin19.7%15.0%15.2%15.2%8.5%11.1%14.7%14.2%11.8%12.4%19.4%11.5%
EPS · diluted$2.98$2.05$2.14$2.16$1.41$1.69$2.29$2.22$2.20$1.93$3.30$1.96
Diluted weighted average shares384M385M385M386M386M386M386M387M387M387M386M385M
Basic weighted average shares380M380M381M381M381M382M382M382M382M383M384M382M
EBITDA$1.82B$1.33B$1.41B$1.46B$927.0M$1.20B$1.50B$1.54B$2.22B$1.33B$2.06B$1.43B
EBITDA margin31.3%25.3%25.9%26.5%14.4%20.4%24.9%25.4%31.0%22.1%31.3%21.9%
Depreciation & amortization$563.0M$355.0M$354.0M$371.0M$346.0M$361.0M$387.0M$402.0M$417.0M$397.0M$404.0M$397.0M
Stock-based compensation$40.00M$87.00M$46.00M$51.00M$45.00M$84.00M$49.00M$62.00M$48.00M$87.00M$54.00M$67.00M
Dividends per share—$0.80$0.80$0.80—$0.84$0.84$0.84—$0.88$0.88$0.88

The main figures as JSON and plain text. See data and methodology.

SYK in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.